ASCEND trial shows aspirin helps prevent significant vascular events in diabetic adults, but at expense of bleeding whereas omega-3 fatty acid supplements adds no benefit
A randomized trial of 15,480 adults in the UK who had diabetes but no evidence of cardiovascular disease showed mixed results for aspirin use and no benefit for use of omega-3 fatty acids in preventing serious vascular events at 7.4 years follow-up, according to findings presented Sunday at the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany.